Genetic Testing Referral Recommendation
Yes, this patient should be referred for genetic counseling and testing based on the family history of prostate cancer in a first-degree relative (father), which meets established criteria for genetic evaluation. 1
Rationale for Referral
The 2024 ASCO-Society of Surgical Oncology guideline explicitly states that genetic testing should be offered when results will inform personal risk management or family risk assessment 1. Your patient's family history includes:
- Father with prostate cancer (first-degree relative)
- Half-sister with HER2-positive breast cancer (second-degree relative)
Key Decision Points
The father's prostate cancer is the critical factor here. While the half-sister's breast cancer is relevant, the paternal prostate cancer creates a potential hereditary cancer syndrome pattern that warrants evaluation. Prostate cancer has substantial heritable components, with up to 10% of cases being inherited, and these mutations often overlap with genes causing breast and ovarian cancer syndromes 2.
The NCCN 2020 guidelines emphasize that testing should be considered when there is "personal or family history suggesting genetic cancer susceptibility" 3. A first-degree relative with prostate cancer combined with a family history of breast cancer (even in a half-sibling) creates a pattern suggestive of possible BRCA2, PALB2, or other hereditary cancer syndrome mutations.
What Testing Should Include
If genetic testing proceeds, it should include at minimum:
- BRCA1/BRCA2 (particularly BRCA2, given the prostate cancer connection)
- PALB2
- Consider broader panel testing including TP53, PTEN, ATM, and CHEK2 based on detailed family history 1
BRCA2 mutations are particularly associated with both breast and prostate cancer risk, making this combination of family history especially relevant 2.
Important Caveats
The HER2-positive status of the sister's breast cancer is not the driving factor for referral. Research shows that HER2-positive breast cancer in young patients without strong family history has low rates of BRCA mutations (only 2% BRCA1 and 2% BRCA2) 4. However, the HER2 status is essentially irrelevant to the genetic testing decision—it's the presence of breast cancer in the family combined with prostate cancer that matters.
The half-sibling relationship doesn't exclude referral. While half-siblings share only one parent, if they share the father (who has prostate cancer), they could both inherit a paternal mutation. If they share the mother, the pattern still suggests familial cancer clustering worth evaluating.
Practical Implementation
The patient should be referred to a genetic counselor or provider experienced in clinical cancer genetics who will:
- Construct a detailed three-generation pedigree
- Determine which specific genes to test based on the complete family history
- Calculate pre-test probability of finding a pathogenic variant
- Provide appropriate pre- and post-test counseling 3, 1
Even if testing is negative, the patient may still benefit from enhanced surveillance based on family history alone 1.